Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LASST: Stepping Down Therapy in Well-Controlled Asthma
NCT01437995Phase 4Completed
- Sponsor
- Johns Hopkins University
- Start
- Mar 2012
- Primary completion
- Sep 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fluticasone propionate and salmeterol in asthma (3 arms), sponsored by Johns Hopkins University. Primary endpoint: Treatment Failure at 48 weeks. Started Mar 2012; status: completed.
02
Drugs
fluticasone propionatesalmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01437995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01437995.